Cardiac Ablation Devices Market is Anticipated to Surge at a CAGR of 12.78% and is also Contemplated to Reach USD 4.12 Billion by 2026, Analyzes DelveInsight

Cardiac Ablation Devices Market is Anticipated to Surge at a CAGR of 12.78% and is also Contemplated to Reach USD 4.12 Billion by 2026, Analyzes DelveInsight

PR Newswire

LAS VEGAS, Dec. 15, 2021

- There is a huge increment observed in the Cardiac Ablation Devices market due to the rising prevalence of patients afflicted with cardiovascular disorders and the benefits offered by cardiac ablation procedures over conventional, therapeutic, and surgical procedures. Also, an increase in the demand for Cardiac Ablation Devices will drive the Cardiac Ablation Devices market growth.

LAS VEGAS, Dec. 15, 2021 /PRNewswire/ -- DelveInsight's Cardiac Ablation Devices Market Insights and Forecast report provides the current and forecast Cardiac Ablation Devices Market, upcoming innovation in the devices, individual market shares, challenges, drivers and barriers, market trends, and key competitors in the Cardiac Ablation Devices Market. 

DelveInsight Logo

Some of the salient features from the Cardiac Ablation Devices Market report: 

To pick on the latest highlights related to Cardiac Ablation Devices, get the snapshot of the key highlights entailed in the Cardiac Ablation Devices Market report.

Cardiac Ablation Devices Overview 

Cardiac Ablation Devices are devices that are used as a minimally invasive option for the treatment of atrial fibrillation. Ablation is routinely performed using radiofrequency (RF) and cryoballoon (CB) catheters, with RF catheters being the most widely used technology. Cardiac Ablation comprises energy for making smaller scars in the heart tissue. It can be also used for the treatment of atrial fibrillation, a type of irregular heartbeat. Cardiac Ablation is a surgical technique that can correct cardiac arrhythmias by scarring tiny regions of the heart. Cardiac arrhythmias arise where there is a deficiency of the electrical impulses that regulate the heartbeats. As a consequence, heartbeats are irregular and can lead to stroke or heart failure if left untreated, and are one of the main causes of death.

Interested in knowing about Cardiac Ablation Devices Market growth by 2026? Click to get a snapshot of Cardiac Ablation Devices Market Analysis

Cardiac Ablation Devices Market Insight 

Geographically, the global Cardiac Ablation Devices market is studied for North America, Europe, Asia-Pacific, and the Rest of the World. In terms of market share, North America tends to dominate the global Cardiac Ablation Devices market in the present scenario and is expected that it will continue to dominate during the forecast period. However, the domination exhibited by North America will be conspicuously challenged by the European market. This supremacy witnessed is attributed to the rising prevalence of cardiovascular disorder, a growing number of cases of atrial fibrillation, technological advancements in the field of Cardiac Ablation, and already established key manufacturers in the North American region. Also, there are great opportunities for market penetration for European regions as the major companies already have a grip in developed regions. 

On June 23, 2021, FDA had received expanded approval for Medtronic's Arctic Front Family of Cardiac Cryoablation Catheters for the treatment of recurrent symptomatic paroxysmal atrial fibrillation (AFib).  Also, several approvals of the Cardiac Ablation Devices such as on January 27, 2020, Imricor Medical Systems, Inc. had announced that it has received CE mark approval for its Vision-MR Ablation Catheter and Vision-MR Dispersive Electrode. Additionally, J&J's Biosense had also received CE Mark for the QDOT MICRO Ablation Catheter.

To know more why North America is the leader in market growth for the Cardiac Ablation Devices market, get a snapshot of the report Cardiac Ablation Devices market

Cardiac Ablation Devices Market Dynamics

Due to the increase in the prevalence of cardiovascular disorders, there will be a higher demand for Cardiac Ablation Devices. Also, with favorable reimbursement policies, the presence of many key players, technological benefits such as being minimally invasive, promising long-term survival, and a multimodal approach, positively influence the overall Cardiac Ablation Devices market. Other factors such as lower cost of radiofrequency ablation, and ease of use will also support the growth of the Cardiac Ablation Devices market globally. Further, growth in new therapies, technological advancements, increasing geriatric population, and penetration and acceptance, approval, and launch of technologically advanced devices in the market will assertively lead to a boost in the Cardiac Ablation Devices market.

The market for Cardiac Ablation Devices had observed a period of reduced growth owing to the outbreak of COVID-19. Owing to the COVID-19 pandemic situation, various forms of elective procedures were temporarily stopped in contrast to the COVID-19 affected patients that were given utmost priority. Apart from this, several other factors including the lockdown-related restrictions, patient reluctance to visit the hospitals and clinics, logistical issues, and the temporary closing of manufacturing companies had further affected the healthcare system.

To get a deeper understanding of the driving factors related to the Cardiac Ablation Devices market, find a snapshot of the Cardiac Ablation Devices Market Dynamics.

Scope of the Cardiac Ablation Devices Market Report

Study Period: 2018-2026

Key Companies: Abbott Laboratories, Boston Scientific Corporation, Avanos Medical, Inc., Auris Health, Inc., Olympus, CONMED Corporation, ERBE ELEKTROMEDIZIN GMBH, AngioDynamics, Medtronic Inc., AtriCure, Inc., Biosense Webster, Inc., Teleflex Incorporated, St. Jude Medical Inc., Lepu Medical Technology (Beijing) Co., Ltd., MicroPort Scientific Corporation, and others.

Cardiac Ablation Devices Market Segmentation

By Product 

By Technology

By Application

By End-User

By Geography

Delveinsight Analysis: The Cardiac Ablation Devices market is expected to grow at a CAGR of 12.78% and will reach USD 4.12 billion by 2026.

Table of Contents 

1

Cardiac Ablation Devices Market Report Introduction

2

Cardiac Ablation Devices Market Executive summary

3

Regulatory and Patent Analysis

4

Cardiac Ablation Devices Market Key factors Analysis

5

Cardiac Ablation Devices Porter's Five Forces Analysis

6

COVID-19 Impact Analysis on Cardiac Ablation Devices Market

7

Cardiac Ablation Devices Market Layout

8

Cardiac Ablation Devices Global Company Share Analysis – Key 3-5 Companies

9

Cardiac Ablation Devices Market Company and Product Profiles


9.1 Abbott Laboratories

9.2 Boston Scientific Corporation

9.3 Avanos Medical, Inc.

9.4 Auris Health, Inc.

9.5 Olympus

9.6 CONMED Corporation

9.7 ERBE ELEKTROMEDIZIN GMBH

9.8 AngioDynamics

9.9 Medtronic Inc.

9.10 AtriCure, Inc.

9.11 Biosense Webster, Inc.

9.12 Teleflex Incorporated

9.13 St. Jude Medical Inc.

9.14 Lepu Medical Technology (Beijing)Co., Ltd.

9.15 MicroPort Scientific Corporation

10

Project Approach

11

KOL Views

12

About DelveInsight

13

Disclaimer & Contact Us

Learn more about the report offerings @ Cardiac Ablation Devices Market Outlook

Understand the Competition, Risk Assessment, and effective Research and Development approach to take value-based decisions.

Related Reports

Cardiac Valvulotome Market

"DelveInsight's 'Cardiac Valvulotome - Market Insight, Competitive Landscape and Market Forecast, 2026' report delivers an in-depth understanding of Cardiac Valvulotome and the historical and forecasted Cardiac Valvulotome market trends, globally, which comprises of North America, Europe, APAC, and RoW, market drivers & barriers, unmet needs, and key companies involved such as Braun Melsungen AG, LeMaitre Vascular, Inc., Andramed GmbH,BD., InvaMed, Koven Technology Canada Inc, and others.

Cardiac Resynchronization Therapy Market

"DelveInsight's 'Cardiac Resynchronization Therapy - Market Insight, Competitive Landscape and Market Forecast, 2026' report delivers an in-depth understanding of Cardiac Resynchronization Therapy and the historical and forecasted Cardiac Resynchronization Therapy market trends, globally, which comprises of North America, Europe, APAC, and RoW, market drivers & barriers, unmet needs, and key companies involved such as Boston Scientific Corporation, Medtronic, Medico S.p. A, Microport Scientific Corporation, Biotronik, EBR Systems, Abbott, and others.

Cardiac Restoration Systems Market 

"DelveInsight's 'Cardiac Restoration Systems - Market Insight, Competitive Landscape and Market Forecast, 2026' report delivers an in-depth understanding of Cardiac Restoration Systems and the historical and forecasted Cardiac Restoration Systems market trends, globally, which comprises of North America, Europe, APAC, and RoW, market drivers & barriers, unmet needs, and key companies involved such as Abbott, BioVentrix,CryoLife, Edwards Lifesciences Corporation,NeoChord, XELTIS, and others.

Cardiac Output Monitors Market 

"DelveInsight's 'Cardiac Output Monitors - Market Insight, Competitive Landscape and Market Forecast, 2026' report delivers an in-depth understanding of Cardiac Output Monitors and the historical and forecasted Cardiac Output Monitors market trends, globally, which comprises of North America, Europe, APAC, and RoW, market drivers & barriers, unmet needs, and key companies involved such as Osypka Medical GmbH, CNSystems Medizintechnik GmbH., Uscom,Deltex Medical Limited, Edward Lifesciences Corporation, ICU Medical, Inc., LiDCO, Baxter., Getinge AB., GE Healthcare (GENERAL ELECTRIC COMPANY), Biotronik, and others.

Cardiac Monitoring Devices Market

Global Cardiac Monitoring Devices Market report delivers an in-depth understanding of Cardiac Monitoring Devices and the historical and forecasted Cardiac Monitoring Devices market trends, market drivers & barriers, unmet needs, and key companies involved such as Medtronic, Boston Scientific, Abbott Laboratories, GE Healthcare, BIOTRONIK, and Koninklijke Philips, Asahi Kasei Corporation, MicroPort Scientific Corporation, Hill-Rom Holdings, Nihon Kohden, SCHILLER AG, BioTelemetry, BPL Medical Technologies, ACS Diagnostics, and others.

Cardiac Biomarkers Testing Market

Global Cardiac Biomarkers Testing Market was valued at USD 3.25 billion in 2020, growing at a CAGR of 7.76% during the forecast period from 2021 to 2026 to reach USD 5.07 billion by 2026. The report delivers an in-depth understanding of Global Cardiac Biomarkers Testing and the historical and forecasted Global Cardiac Biomarkers Testing market trends, market drivers & barriers, unmet needs, and key companies involved such as Beckman Coulter, Siemens Healthcare GmbH, Abbott, bioMérieux SA, F. Hoffmann-La Roche Ltd, Thermo Fischer Scientific Inc, Bio-Rad Laboratories Inc, Eurolyser Diagnostica GmbH, Diagnostic Automation / Cortez Diagnostics, Randox Laboratories Ltd, Tosoh Corporation, DIALAB GmbH, CardioGenics Holdings Inc, and others.

Cardiac Assist Devices Market 

Global Cardiac Assist Devices Market was valued at USD 2.55 billion in 2020, growing at a CAGR of 13.70% during the forecast period from 2021 to 2026, to reach USD 5.50 billion by 2026. The report delivers an in-depth understanding of Global Cardiac Assist Devices and the historical and forecasted Global Cardiac Assist Devices market trends, market drivers & barriers, unmet needs, and key companies involved such as Abbott Laboratories, Teleflex Incorporated, SynCardia Systems, LLC, St. Jude Medical Inc, CARMAT, CorWave SA, Medtronic PLC, Terumo Heart, NovaPump GmbH, Getinge AB Balton Ltd, Meril Life Sciences Pvt. Ltd, Thoratec Corporation, and others.

3D Cardiac Mapping System Market 

"DelveInsight's '3D Cardiac Mapping System - Market Insight, Competitive Landscape and Market Forecast, 2026' report delivers an in-depth understanding of 3D Cardiac Mapping System and the historical and forecasted 3D Cardiac Mapping System market trends, globally, which comprises of North America, Europe, APAC, and RoW, market drivers & barriers, unmet needs, and key companies involved such as Biosense Webster, (Jhonson & Jhonson), Boston Scientific Corporation, Abbott, Kardium, Medtronic, Catheter Robotics, Inc, Lepu Medical, EP Solutions SA, and others.

Browse Through Our Blog Posts

Connect With Us at LinkedIn | Facebook | Twitter

Contact Us
Shruti Thakur 
info@delveinsight.com 
+1(919)321-6187 
www.delveinsight.com

Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg  

Voltar noticias em Inglês